CORBIN CAPITAL PARTNERS, L.P. sold 2.32M shares of TEVOGEN BIO HOLDINGS INC. on the open market
Open‑market sale worth $24.78M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/18/2023ACC: 0000895345-23-000411
10% Owner
Since Feb 2023
-2.32M
Net shares
Net seller
$24.78M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.32M disposed
Non-Derivative Transactions2
Class A Ordinary Shares, par value $0.0001 per share
Indirect
Shares
−603.20K
Price / share
$10.68
Trade value
$6.44M
% of position
New position
7/17/2023
603.20K→0.00
Class A Ordinary Shares, par value $0.0001 per share
Indirect
Shares
−1.72M
Price / share
$10.68
Trade value
$18.34M
% of position
New position
7/17/2023
1.72M→0.00
Total
Net shares
−2.32M
Net value
-$24.78M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares, par value $0.0001 per share Indirect | 7/17/2023 | S · Sale | −603.20K | $10.68 | $6.44M | New position | 603.20K | 0.00 |
| Class A Ordinary Shares, par value $0.0001 per share Indirect | 7/17/2023 | S · Sale | −1.72M | $10.68 | $18.34M | New position | 1.72M | 0.00 |
| Total | −2.32M | -$24.78M | ||||||
Derivative Transactions0
No derivative transactions reported